We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
26
Salesforce
CRM
$134B
$103M 0.7%
380,236
+6,493
+2% +$1.65M
PANW icon
27
Palo Alto Networks
PANW
$264B
$99.8M 0.68%
1,249,884
-25,152
-2% -$1.77M
C icon
28
Citigroup
C
$222B
$97.2M 0.66%
1,384,621
-79,593
-5% -$5.56M
A icon
29
Agilent Technologies
A
$39.1B
$97M 0.66%
615,856
-272
-0% -$44K
PYPL icon
30
PayPal
PYPL
$49.5B
$96.1M 0.65%
369,393
-5,164
-1% -$1.47M
TSLA icon
31
Tesla
TSLA
$1.24T
$93.3M 0.63%
360,828
-61,440
-15% -$14.5M
TSM icon
32
TSMC
TSM
$2.09T
$92.5M 0.63%
828,709
+39,722
+5% +$4.66M
WM icon
33
Waste Management
WM
$95.9B
$92.1M 0.63%
616,823
-49,463
-7% -$7.4M
SBUX icon
34
Starbucks
SBUX
$118B
$91.6M 0.62%
830,284
+246,840
+42% +$28.9M
CRL icon
35
Charles River Laboratories
CRL
$10.9B
$91.1M 0.62%
220,705
-17,442
-7% -$7.24M
ILMN icon
36
Illumina
ILMN
$29.4B
$90.7M 0.62%
229,909
+28,128
+14% +$12.9M
NKE icon
37
Nike
NKE
$61.9B
$89.9M 0.61%
619,235
-26,893
-4% -$4.38M
AMAT icon
38
Applied Materials
AMAT
$426B
$83.4M 0.57%
648,156
+6,429
+1% +$873K
QCOM icon
39
Qualcomm
QCOM
$176B
$83.3M 0.57%
645,722
-26,441
-4% -$3.75M
HD icon
40
Home Depot
HD
$332B
$81.2M 0.55%
247,471
+5,749
+2% +$1.89M
MRNA icon
41
Moderna
MRNA
$21.5B
$80.3M 0.55%
208,555
-98,459
-32% -$36.3M
ON icon
42
ON Semiconductor
ON
$33.8B
$80M 0.54%
1,747,639
+225,374
+15% +$9.63M
XLRN
43
DELISTED
Acceleron Pharma
XLRN
$79.5M 0.54%
462,239
-94,816
-17% -$12.4M
BIIB icon
44
Biogen
BIIB
$29.9B
$77.2M 0.52%
272,643
-2,397
-0.9% -$786K
MELI icon
45
Mercado Libre
MELI
$91.3B
$75.8M 0.52%
45,120
+23,483
+109% +$40.7M
AMD icon
46
Advanced Micro Devices
AMD
$851B
$72.6M 0.49%
705,340
-154,921
-18% -$15.8M
SQM icon
47
Sociedad Química y Minera de Chile
SQM
$19.6B
$72M 0.49%
1,339,455
+569,660
+74% +$29.1M
ROK icon
48
Rockwell Automation
ROK
$51.4B
$71.9M 0.49%
244,433
+16,710
+7% +$5.13M
ABT icon
49
Abbott
ABT
$180B
$68.7M 0.47%
581,239
-79,305
-12% -$9.74M
MRTX
50
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$67.8M 0.46%
383,219
+37,623
+11% +$6.05M
1
2
3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.